Clinical Trials Browser

INDUSTRY × Advanced/Metastatic Solid Tumors × pembrolizumab × Clear all

NCT05405595 2026-01-07

ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Advanced/Metastatic Solid Tumors

NCT05277402 2024-02-26

ADG116 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors

Phase 1 Completed

Other solid neoplasm

Advanced/Metastatic Solid Tumors